Figure 2: Serial changes of the right orbital pseudotumor and protrusive uveal mass before and after systemic steroid pulse therapy for sympathetic ophthalmia. (a) An extensive pinkish elevated mass was seen at superior-temporal quadrant of the conjunctiva five months before the onset of sympathetic ophthalmia (black arrow). (b) Scleral necrosis with uveal tissue protrusion developed at the thinned sclera, while the computed tomographic scan showed a more extensive orbital pseudotumor (black arrow). (c) With more bulging of the uveal mass, sympathetic ophthalmia was incited in both eyes. (d) After high-dose steroid therapy, the uveal mass flattened with conjunctival tissue growing over its surface. (e) Six weeks after onset of sympathetic ophthalmia, the computed tomographic scan showed shrinking orbital pseudotumor (black arrow) and a silent, smooth uveal tissue beneath the thinned sclera was seen. (f) Four years later, conjunctival epithelialization and vessels growth were noticed over the previous scleral perforation site